EGFR and colonic neoplasm: The results showed that many cancer-related pathways were enriched in high-risk groups such as cellular response to hypoxia, glycolysis and gluconeogenesis, metabolic reprogramming in colon cancer, APC mediated degradation of cell cycle proteins, signaling by EGFR (Figure 6A).